Browse Protocols by Category Weight Management & Metabolic Peptides These protocols cover GLP-1 receptor agonists and related compounds studied for weight loss, appetite regulation, and metabolic health
HUBERMAN: The typical therapeutic doses that are prescribed are anywhere from 300 to 500 micrograms subcutaneously, maybe two or three times per week
The goal is not to block patients from learning about emerging therapies
So the problem has always been, how can we keep it stable before the body recognizes and tries to degrade it enzymatically
First time going here and I will definitely be back
A reasonable harm reduction approach for people on cardiovascular medications includes informing healthcare providers about BPC-157 use, starting with conservative doses, monitoring blood pressure and other relevant parameters closely, watching for any changes in medication effectiveness, and being prepared to discontinue if unexpected effects emerge
